Barrier function and microbiotic dysbiosis in atopic dermatitis

References

• BieberTAtopic dermatitisN Engl J Med2008358141483149418385500
   PubMed Web of Science ®Google Scholar
• DharmageSCLoweAJMathesonMCBurgessJAAllenKJAbramsonMJAtopic dermatitis and the atopic march revisitedAllergy201369172724117677
   PubMed Web of Science ®Google Scholar
• RingJAlomarABieberTGuidelines for treatment of atopic eczema (atopic dermatitis) part IJ Eur Acad Dermatol Venereol20122681045106022805051
   PubMed Web of Science ®Google Scholar
• EichenfieldLFTomWLChamlinSLGuidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitisJ Am Acad Dermatol201470233835124290431
   PubMed Web of Science ®Google Scholar
• EyerichKNovakNImmunology of atopic eczema: overcoming the Th1/Th2 paradigmAllergy201368897498223889510
   PubMed Web of Science ®Google Scholar
• SmithFJIrvineADTerron-KwiatkowskiALoss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgarisNat Genet200638333734216444271
   PubMed Web of Science ®Google Scholar
• BoguniewiczMLeungDYAtopic dermatitis: a disease of altered skin barrier and immune dysregulationImmunol Rev2011242123324621682749
   PubMed Web of Science ®Google Scholar
• KuoIHYoshidaTDe BenedettoABeckLAThe cutaneous innate immune response in patients with atopic dermatitisJ Allergy Clin Immunol2013131226627823374259
   PubMed Web of Science ®Google Scholar
• KongHHOhJDemingCTemporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitisGenome Res201222585085922310478
   PubMed Web of Science ®Google Scholar
• SchmittJvon KobyletzkiLSvenssonAApfelbacherCEfficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trialsBr J Dermatol2011164241542820819086
   PubMed Web of Science ®Google Scholar
• RingJAlomarABieberTGuidelines for treatment of atopic eczema (atopic dermatitis) Part IIJ Eur Acad Dermatol Venereol20122691176119322813359
   PubMed Web of Science ®Google Scholar
• SimonDBieberTSystemic therapy for atopic dermatitisAllergy2014691465524354911
   PubMed Web of Science ®Google Scholar
• BieberTStraeterBOff-label prescriptions for atopic dermatitis in EuropeAllergy201570161125074686
   PubMed Web of Science ®Google Scholar
• HowellMDParkerMLMustelinTRanadeKPast, present, and future for biologic intervention in atopic dermatitisAllergy201570888789625879391
   PubMed Web of Science ®Google Scholar
• LaneMEHadgraftJOliveiraGVieiraRMohammedDHirataKRational formulation designInt J Cosmet Sci201234649650122882873
   PubMed Web of Science ®Google Scholar
• HonKLChingGKLeungTFChoiCYLeeKKNgPCEstimating emollient usage in patients with eczemaClin Exp Dermatol2010351222619489850
   PubMed Web of Science ®Google Scholar
• DrenoBAraviiskaiaEBerardescaEThe science of dermocosmetics and its role in dermatologyJ Eur Acad Dermatol Venereol201428111409141724684296
   PubMed Web of Science ®Google Scholar
• GriceEAKongHHConlanSTopographical and temporal diversity of the human skin microbiomeScience200932459311190119219478181
   PubMed Web of Science ®Google Scholar
• GriceEASegreJAThe human microbiome: our second genomeAnnu Rev Genomics Hum Genet20121315117022703178
   PubMed Web of Science ®Google Scholar
• OngPYOhtakeTBrandtCEndogenous antimicrobial peptides and skin infections in atopic dermatitisN Engl J Med2002347151151116012374875
   PubMed Web of Science ®Google Scholar
• NakatsujiTGalloRLAntimicrobial peptides: old molecules with new ideasJ Invest Dermatol20121323 pt 288789522158560
   PubMed Web of Science ®Google Scholar
• GriceEAThe skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous diseaseSemin Cutan Med Surg20143329810325085669
   PubMed Web of Science ®Google Scholar
• SeiteSFloresGEHenleyJBMicrobiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatmentJ Drugs Dermatol201413111365137225607704
   PubMed Web of Science ®Google Scholar
• GriceEASegreJAThe skin microbiomeNat Rev Microbiol20119424425321407241
   PubMed Web of Science ®Google Scholar
• YamamuraSMoritaYHasanQYokoyamaKTamiyaEKeratin degradation: a cooperative action of two enzymes from Stenotrophomonas spBiochem Biophys Res Commun2002294511381143 Erratum in: Biochem Biophys Res Commun. 2002;295(4):103412074595
   PubMed Web of Science ®Google Scholar
• HuangJTAbramsMTlouganBRademakerAPallerASTreatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severityPediatrics20091235e808e81419403473
   PubMed Web of Science ®Google Scholar
• PanduruMPanduruNMSalavastruCMTiplicaGSProbiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studiesJ Eur Acad Dermatol Venereol201529223224224698503
   PubMed Web of Science ®Google Scholar
• MuraroAHalkenSArshadSHEAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergyAllergy201469559060124697491
   PubMed Web of Science ®Google Scholar
• KimSOAhYMYuYMChoiKHShinWGLeeJYEffects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trialsAnn Allergy Asthma Immunol2014113221722624954372
   PubMed Web of Science ®Google Scholar
• WangIJWangJYChildren with atopic dermatitis show clinical improvement after Lactobacillus exposureClin Exp Allergy201545477978725600169
   PubMed Web of Science ®Google Scholar
• DragoLDe VecchiEToscanoMVassenaCAltomareGPigattoPTreatment of atopic dermatitis eczema with a high concentration of Lactobacillus salivarius LS01 associated with an innovative gelling complex: a pilot study on adultsJ Clin Gastroenterol201448Suppl 1S47S5125291127
   PubMed Web of Science ®Google Scholar
• NiccoliAAArtesiALCandioFPreliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitisJ Clin Gastroenterol201448Suppl 1S34S3625291124
   PubMed Web of Science ®Google Scholar
• GuenicheAKnaudtBSchuckEEffects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical studyBr J Dermatol200815961357136318795916
   PubMed Web of Science ®Google Scholar
• VolzTSkabytskaYGuenovaENonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cellsJ Invest Dermatol201413419610423812300
   PubMed Web of Science ®Google Scholar
• MaheYFPerezMJTacheauCA new Vitreoscilla filiformis extract grown on spa water-enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll-like receptor 2/protein kinase C, zeta transduction pathwayClin Cosmet Investig Dermatol20136191196
   Google Scholar
• SeitéSZelenkovaHMartinRFiererNUsing a Specific Emollient to Manage Skin Microbiome DysbiosisVancouver, CanadaWorld Congress of Dermatology2015
   Google Scholar
• BiedermannTSkabytskaYKaeslerSVolzTRegulation of T cell immunity in atopic dermatitis by microbes: the Yin and Yang of cutaneous inflammationFront Immunol2015635326217343
   PubMed Web of Science ®Google Scholar
• FlohrCMannJNew approaches to the prevention of childhood atopic dermatitisAllergy2014691566124372089
   PubMed Web of Science ®Google Scholar
• SimpsonELChalmersJRHanifinJMEmollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionJ Allergy Clin Immunol2014134481882325282563
   PubMed Web of Science ®Google Scholar
• FukuieTNomuraIHorimukaiKProactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitisBr J Dermatol201016351127112920545693
   PubMed Web of Science ®Google Scholar